Thursday, July 16, 2026
2:15 PM – 3:30 PM
Harbor 3&4
Oral Abstract Session 2
Moderators:
Okeoma Mmeje (University of Michigan Medical School, Department of Obstetrics and Gynecology) & Emily Trautner (Centers for Disease Control and Prevention)
2:15 PM – 2:30 PM
Selective Human-Milk-Inspired Antimicrobial Peptides for the Treatment of Bacterial Vaginosis (#005)
Speaker:
Ishita Shah (Matrubials Inc.)
2:30 PM – 2:45 PM
Microbiome-Defined BV Subtypes Are Associated With Distinct Recurrence Burden Among Participants Meeting Standard BV Criteria (#006)
Speaker:
Rob Markowitz (Evvy)
2:45 PM – 3:00 PM
Boric Acid Impairs Lactobacillus crispatus Growth and Lactic Acid Production (#007)
Speaker:
Piper Kinney (Vincent Center for Reproductive Biology, Massachusetts General Hospital and Simmons University)
3:00 PM – 3:15 PM
The Role of Lactobacillus iners Dominated Vaginal Microbiota and Sexual Activity in Incident Bacterial Vaginosis Pathogenesis (#008)
Speaker:
Christopher M. Taylor (Department of Microbiology, Immunology, and Parasitology/Louisiana State University Health Sciences Center – New Orleans)
3:15 PM – 3:30 PM
In vitro Activity of a Novel Ozonated Oil Formulation Against Isolates of Trichomonas vaginalis (#009)
Speaker:
Keonte Graves (Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham)